Recent findings have revealed that GPR81 expressed on dendritic cells within the tumor microenvironment suppresses MHC II surface expression and cytokine production, thereby impairing antigen presentation and dampening T cell activation [49]. This evidence concerns the gene HCAR1 and neoplasm.